BioCentury
ARTICLE | Company News

Akouos licenses gene therapy tech from Massachusetts Eye and Ear

December 8, 2017 2:53 AM UTC

Newco Akouos Inc. (Boston, Mass.) acquired an exclusive license to a vector platform from Massachusetts Eye and Ear (Boston, Mass.) and Lonza Group Ltd. (SIX:LONN) to develop gene therapies for hearing and balance disorders. The license includes sublicensing rights.

The platform includes 40,000 in silico-designed ancestral adeno-associated virus (AAV) vectors developed by Luk Vandenberghe at Massachusetts Eye and Ear. ...